Home > Healthcare > Medical Devices > Therapeutic Devices > Insulin Delivery Devices Market

Insulin Delivery Devices Market Share

Report ID: GMI1649
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Insulin Delivery Devices Market Share

Some of the major players operating in the insulin delivery devices market

Novo Nordisk A/S
Ypsomed Holdings AG
Medtronic plc
Tandem Diabetes Care
Sanofi
Biocon
Eli Lilly & Company
Insulet Corporation
Roche
B Braun Melsungen AG

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Insulin delivery devices market size was USD 16.9 billion in 2022 and will reach over USD 46.3 billion by 2032 due to the increasing prevalence of diabetes worldwide.

The insulin pumps device type segment will witness 12.3% CAGR from 2023-2032 on account of benefits, such as, affordable price, user-friendly design, and technological advancements.

U.S. industry registered over USD 19 billion in revenue in 2022 and is expected to witness significant CAGR from 2023-2032 owing to the growing burden of diabetic conditions in the region.

Novo Nordisk A/S, Ypsomed Holdings AG, Medtronic plc, Tandem Diabetes Care, Sanofi, Biocon, Eli Lilly & Company, Insulet Corporation, Roche, and B Braun Melsungen AG are some of the major insulin delivery device companies worldwide.